| 131 |
Concurrent Radiochemotherapy in Locally Advanced Head and Neck Cancer: Analysis of Treatment Results and Prognostic factors |
2015 |
| 132 |
Concurrent Radiochemotherapy in Locally Advanced Head and Neck Cancer: Analysis of Treatment Results and Prognostic factors |
2015 |
| 133 |
CONCURRENT RADIOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK CANCER: ANALYSIS OF TREATMENT RESULTS AND PROGNOSTIC FACTORS |
2015 |
| 134 |
CONCURRENT RADIOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK CANCER: ANALYSIS OF TREATMENT RESULTS AND PROGNOSTIC FACTORS |
2015 |
| 135 |
Definitive 3D Concurrent Chemoradiotherapy in Locally Advanced Pancreatic Cancer |
2015 |
| 136 |
Definitive 3D Concurrent Chemoradiotherapy in Locally Advanced Pancreatic Cancer |
2015 |
| 137 |
GDP versus DHAP in relapsed and refractory Hodgkin disease |
2015 |
| 138 |
GDP versus DHAP in relapsed and refractory Hodgkin disease |
2015 |
| 139 |
GDP versus DHAP in relapsed and refractory Hodgkin disease |
2015 |
| 140 |
METRONOMIC CAPECITABINE WITH VINORELBINE AS A SECOND LINE CHEMOTHERAPY IN ADVANCED BREAST CANCER |
2015 |